CF
CDMO

Centaurus Financial’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Centaurus Financial’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-11
Closed – – 2110
2018
Q2 		$0 Buy
+11
New +$38 ﹤0.01% 2426

Other funds holding CDMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
BP
Bandera Partners New York $221M AUM 10.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SIC
Schwartz Investment Counsel Plymouth, Michigan $2.82B AUM 13.66% 1-Year Est. Return

Centaurus Financial's CDMO Position: Q3 2018 in Review

Centaurus Financial sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q3 2018, closing a stake of 11 shares.

Centaurus Financial first reported a position in CDMO in Q2 2018 and held it in 1 quarter. The position peaked at $0 in Q2 2018. 101 funds tracked by Wall St. Rank hold CDMO as of Q3 2018.

  • Centaurus Financial reported no remaining Avid Bioservices, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
  • Centaurus Financial sold 11 Avid Bioservices, Inc. Common Stock shares in Q3 2018.
  • Centaurus Financial first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2018 and held it in 1 quarter.
  • Centaurus Financial's Avid Bioservices, Inc. Common Stock position peaked at $0 in Q2 2018.
  • 101 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q3 2018.

Based on Centaurus Financial's 13F filing for Q3 2018, filed 5 Nov 2018.